Delayed audit great opportunity to prepare and execute when approved .....but didn't work out that way. Listing high priority but again unable to execute , at least being listed will allow new group of investors to join and more exposure. Other vaccines not "complete" but able to capitalize on potential. Took about 9 months to produce vaccine ......imagine what could be next in another 9 months while GNBT/NGIO are waiting for the "end" result.......really ???? The unlocked value may vaporize in "no value". The present is a great time to reflect on the past ...........hitting 3+ pps all based on trust, promising PR's and upcoming events ...... obviously no results, dilution, no revenue, no listing, toxic funding, trust, integrity and a blurry vision will continue to be a major obstacle to get support and move higher. Just a valuation and Nasdaq target date could be helpful ..........
Exciting times ahead !!
(2)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links